How to Select Your REACH OR for ECHA's 2026 Enforcement Project

With the European Chemicals Agency (ECHA) planning its 2026 enforcement project (REF-14) to specifically target Only Representatives (ORs), non-EU manufacturers face heightened scrutiny. This initiative signals a clear shift from basic registration checks to a more in-depth evaluation of ongoing compliance. For manufacturers, particularly those in complex sectors like medical devices, selecting a truly competent REACH OR is no longer just a legal formality—it is a critical risk management decision. Choosing an OR that offers robust, proactive regulatory oversight is essential for navigating this stricter enforcement landscape. A purely administrative or "letterbox" OR can expose a non-EU manufacturer to significant compliance gaps, potential market access disruption, and financial penalties. Therefore, manufacturers must adopt a rigorous vetting process that goes far beyond verifying a successful registration history. This involves a deep assessment of an OR’s technical expertise, documented management systems, and proven inspection-readiness. ### Key Points * **Beyond Basic Registration:** A competent OR is a long-term compliance partner, not just a one-time service provider. Their role includes ongoing tonnage tracking, supply chain communication, and dossier maintenance. * **Technical Expertise is Crucial:** The OR must possess verifiable technical knowledge of the specific chemical substances being imported, including their uses in complex articles and potential regulatory classifications (e.g., as SVHCs). * **Documented Procedures are Non-Negotiable:** A reliable OR operates under a robust quality system with clear, written procedures for all key REACH obligations, including volume tracking, Safety Data Sheet (SDS) management, and downstream user communication. * **Inspection-Readiness is the New Standard:** With REF-14 on the horizon, an OR’s record-keeping must be comprehensive and audit-proof, extending beyond the registration dossier to include all relevant correspondence and compliance evidence. * **Proactive Oversight vs. Reactive Service:** A strategic OR actively monitors the regulatory landscape for changes that could impact a manufacturer's products and provides proactive guidance, helping to prevent compliance issues before they arise. * **Due Diligence is the Manufacturer's Responsibility:** The legal responsibility for REACH compliance ultimately remains with the non-EU manufacturer. Thoroughly vetting and selecting a qualified OR is a fundamental part of fulfilling that duty. ## Understanding the Shift: Why ECHA's REF-14 Project Matters ECHA's enforcement projects, coordinated by the Enforcement Forum, are EU-wide initiatives that focus on specific areas of chemical regulations to ensure harmonized compliance. The upcoming REF-14 project, scheduled for 2026, has a specific focus on the duties and performance of Only Representatives. This means that national enforcement authorities across the EU will be specifically trained and directed to inspect the operations of ORs. These inspections are expected to be far more rigorous than routine checks. Authorities will likely scrutinize: * **Proof of Mandate:** The legal agreement between the non-EU manufacturer and the OR. * **Dossier Accuracy:** Whether the registration dossier accurately reflects the substance identity, uses, and tonnage bands. * **Tonnage Tracking Systems:** The methods and records used to track the import volumes for all EU importers covered by the OR. * **Supply Chain Communication:** Evidence that the OR is effectively communicating required safety information (e.g., via SDS) down the supply chain. * **Record-Keeping:** The overall quality and completeness of records demonstrating ongoing compliance with all REACH articles. An OR that cannot provide clear, documented evidence in these areas will be found non-compliant, directly impacting the non-EU manufacturer's ability to legally place their products on the EU market. ## Critical Criteria for Vetting an Inspection-Ready REACH OR To ensure a potential OR can withstand this level of scrutiny, manufacturers should evaluate them against a set of critical criteria that go far beyond a simple service agreement. ### 1. Technical and Regulatory Expertise A competent OR must have in-house expertise relevant to the manufacturer's specific products and substances. This is particularly vital for complex products like medical devices, which may contain polymers, additives, colorants, or other materials subject to REACH. **What to Assess:** * **Team Qualifications:** Inquire about the qualifications of the team that will handle the account. Do they have chemists, toxicologists, and regulatory specialists with experience in your industry? * **Substance-Specific Knowledge:** Present them with your substance portfolio. Can they discuss the specific challenges, data requirements, and potential classifications (e.g., SVHC, CLP) for your materials? * **Experience with Complex Articles:** If you manufacture articles, assess their understanding of the "once an article, always an article" principle and the complexities of SVHC notifications to the SCIP database. ### 2. Robust Management Systems and Documented Procedures A reliable OR operates like any other professional service firm—with standardized, documented processes that ensure consistency, accuracy, and auditability. **Key Procedures to Request Evidence Of:** * **Tonnage Tracking Procedure:** They should have a formal system for collecting import data from all of the manufacturer's EU importers, aggregating it, and ensuring tonnage bands are not exceeded. Ask to see a redacted template or a flowchart of this process. * **Supply Chain Communication Protocol:** How do they manage communications with downstream users? They should have a documented process for distributing updated SDSs and responding to inquiries. * **Dossier Maintenance and Update Procedure:** REACH is not static. The OR must have a process for monitoring new substance data or regulatory changes and proactively updating the registration dossier as needed. * **Record-Keeping Policy:** A formal policy that dictates what records are kept, for how long (REACH requires records be kept for at least 10 years after the last import), and in what format. ### 3. Comprehensive and Auditable Record-Keeping During an inspection, officials will demand to see records. An OR’s ability to quickly produce clear, organized, and complete records is a primary indicator of their competence. **Records Should Include:** * The full registration dossier and all associated ECHA correspondence. * A current list of all EU importers covered by the OR agreement. * Detailed tonnage aggregation reports, broken down by importer and time period. * A log of all communications with downstream users regarding safe use information. * Records of all SDS versions and proof of their distribution. ## A Practical Vetting Checklist: Key Questions for Potential ORs When interviewing potential ORs, manufacturers should come prepared with specific, probing questions designed to reveal their true level of preparedness. #### **Category 1: Experience and Inspection-Readiness** 1. Can you describe your experience with past inspections from ECHA or national enforcement authorities, either for your own operations or for your clients? 2. What is your internal audit process for ensuring your own systems and your clients' registrations remain compliant? How frequently are these audits performed? 3. How do you monitor and interpret changes in REACH, CLP, and associated ECHA guidance documents? How is this information communicated to your clients? #### **Category 2: Systems and Processes** 4. Please provide a step-by-step overview of your process for onboarding a new client and their substance portfolio. 5. Can you demonstrate the system you use to track import volumes from multiple EU distributors for a single non-EU manufacturer? What is the reporting frequency? 6. How do you manage the creation, review, and distribution of Safety Data Sheets (SDS)? What triggers an SDS update in your system? #### **Category 3: Technical Competence and Service** 7. Our products involve [e.g., "specialty polymers with proprietary additives"]. What specific experience does your technical team have with such substances? 8. Who would be our day-to-day contact, and what are their qualifications? Will we have direct access to your senior technical or regulatory experts? 9. Can you provide a redacted example of a compliance report or a regulatory update you have sent to a client? ## Finding and Comparing REACH Only Representative Providers Selecting the right OR is a significant decision that requires careful due diligence. Manufacturers should identify and vet at least two to three potential providers to compare their technical capabilities, service models, and overall approach to partnership. When comparing options, look for clear service level agreements (SLAs), transparent pricing structures, and a willingness to provide detailed answers to the questions outlined above. A provider who is hesitant to discuss their internal processes or demonstrate their systems may not be prepared for the level of transparency required in the current enforcement climate. Using a specialized directory can help streamline the process of identifying qualified providers with experience in your industry. To find qualified vetted providers [click here](https://cruxi.ai/regulatory-directories/reach_only_rep) and request quotes for free. ## Key ECHA/REACH References For official information, manufacturers should always consult the primary sources. While a competent OR will manage these details, it is wise to be familiar with the key documents governing their obligations. * **REACH Regulation (EC) No 1907/2006:** The core legal text that establishes the roles and responsibilities of manufacturers, importers, and Only Representatives. * **ECHA Guidance for Only Representatives:** A detailed guidance document from ECHA explaining the specific duties and legal obligations of an OR. * **ECHA Guidance on Registration:** Provides comprehensive information on the registration process, dossier preparation, and data requirements. * **Information on ECHA's Enforcement Projects (REF):** The ECHA website provides public information on current and upcoming enforcement initiatives, including REF-14. *** This article is for general educational purposes only and is not legal, medical, or regulatory advice. For device-specific questions, sponsors should consult qualified experts and consider engaging FDA via the Q-Submission program. --- *This answer was AI-assisted and reviewed for accuracy by Lo H. Khamis.*